3 Studio Sperimentale
3.5 Conclusioni
Il nostro studio ha evidenziato come l’anemia sia una condizione molto frequente nei pazienti critici canini, con un prevalente aspetto non rigenerativo che sembra correlare con uno stato infiammatorio di cui l’ipoalbuminemia rappresenta un marker.
Gli nRBC appaiono un importante fattore prognostico negativo per i pazienti canini in SIRS, mentre il rapporto neutrofili/linfociti sembra comportarsi come un marker d’infiammazione acuta e, per questo motivo, sono auspicabili ulteriori studi per conoscere meglio il ruolo di questo per diagnosi e prognosi dei pazienti in SIRS.
Gli score clinici APPLE e grading di SIRS sono dei fattori in grado di aiutare il clinico nell’inquadramento e nella gestione del paziente critico e, quindi se ne consiglia l’uso per una corretta stratificazione della gravità della malattia e per indirizzare la terapia.
Bibliografia
1 Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W, et al. accplsccm consensus conference for Sepsis and Organ Failure and. Chest. 1992;101:1644–55.
2 Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama [Internet]. 2016;315(8):801
3 Hauptman JG, Walshaw R, Olivier NB. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet Surg [Internet]. 1997;26(5):393–7.
4 Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med [Internet]. 2003;31(0090-3493 (Print)):1250–6. Available from: C:\Karsten\PDFs\Infektiologie-PDFs\Infekt-2003\Levy et al.-2001 SCCM ESICM ACCP ATS SIS International Sepsis Definitions Conference.pdf
5 Lewis DH, Chan DL, Pinheiro D, Armitage-Chan E, Garden OA. The Immunopathology of Sepsis: Pathogen Recognition, Systemic Inflammation, the Compensatory Anti-Inflammatory Response, and Regulatory T Cells. J Vet Intern Med. 2012;26(3):457–82.
6 Matzinger P. Friendly and dangerous signals: Is the tissue in control? Nat Immunol 2007;8:11–13.
7 Frantz S, Ertl G, Bauersachs J. Toll-like receptor signaling in the ischemic heart. Front Biosci 2008;13:5772–5779.
8 Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007;81:1–5.
9 Cinel I, Opal SM. Molecular biology of inflammation and sepsis: A primer. Crit Care Med 2009;37:291–304.
10 Otto CM, Drobatz KJ, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997;11:65–70.
11 Declue AE, Delgado C, Chang CH, et al. Clinical and immunologic assessment of sepsis and the systemic inflammatory response syndrome in cats. J Am Vet Med Assoc 2011;238:890–897.
12 Mark KS, Trickler WJ, Miller DW. Tumor necrosis factor-alpha induces cyclooxygenase- 2 expression and prostaglandin release in brain microvessel endothelial cells. J Pharmacol ExpTher 2001;297:1051–1058.
13 Pober JS, Bevilacqua MP, Mendrick DL, et al. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelialcells. J Immunol 1986;136:1680–1687.
14 Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol 2008;214:211–223.
15 Cavaillon JM, Adib-Conquy M, Fitting C, et al. Cytokine cascade in sepsis. Scand J Infect Dis 2003;35:535–544.
16 Stylianou E, Saklatvala J. Interleukin-1. Int J Biochem Cell Biol 1998;30:1075–1079.
17 Dinarello CA. A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J Immunol 2011;41:1203–1217.
18 wa RS, Anillo S, Huntoon K, et al. Analytic review: Interleukin-6 in surgery, trauma, and critical care: Part I: Basic science. J Intensive Care Med 2011;26:3–12.
19 Scumpia PO, Moldawer LL. Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit Care Med 2005;33:S468–S471.
20 Seitz M, Loetscher P, Dewald B, et al. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol1995;25:1129–1132.
21 Van der Poll T, Van Deventer SJH. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am. 1999;13(2):413–26.
22 de Jong HK, van der Poll T, Wiersinga WJ. The systemic
pro-inflammatory response in sepsis. J Innate Immun 2010;2:422–430.
23 Cray C, Zaias J, Altman NH. Acute phase response in animals: A review. Comp Med 2009;59:517–526.
24 Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257–266.
25 Gruys E, Toussaint MJ, Niewold TA, et al. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005;6:1045–1056.
26 Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: The acute-phase proteins. Protein Pept Lett 2002;9:211–223.
27 Ceron JJ, Eckersall PD, Martynez-Subiela S. Acute phase proteins in dogs and cats: Current knowledge and future perspectives.Vet Clin Pathol 2005;34:85–99.
28 Tvarijonaviciute A, Eralp O, Kocaturk M, et al. Adiponectin
and IGF-1 are negative acute phase proteins in a dog model of acute endotoxaemia. Vet Immunol Immunopathol2011;140:147–151.
29van der Poll T, de Boer JD, Levi M. The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis 2011;24:273–278.
30 Machado FR, Cesar MS. Sepsis, coagulation and anticoagulants. Endocr Metab Immune Disord Drug Targets 2010;10:204–213.
31 Machado FR, Cesar MS. Sepsis, coagulation and anticoagulants. Endocr Metab Immune Disord Drug Targets 2010;10:204–213.
32 Huisse MG, Pease S, Hurtado-Nedelec M, et al. Leukocyte activation: The link between inflammation and coagulation during heatstroke. A study of patients during the 2003 heat wave in Paris. Crit Care Med 2008;36:2288–2295.
34 Bentz AI, Palmer JE, Dallap BL, et al. Prospective evaluation of coagulation in critically ill neonatal foals. J Vet Intern Med 2009;23:161–167.
35 DelGiudice LA, White GA. The role of tissue factor and tissue factor pathway inhibitor in health and disease states. J Vet Emerg Crit Care (San Antonio) 2009;19:23–29.
36 Rogers CL, Rozanski EA. Von Willebrand factor antigen
concentration in dogs with sepsis. J Vet InternMed2010;24:229–230.
37 Oehmcke S, Herwald H. Contact system activation in severe infectious diseases. J Mol Med (Berl) 2010;88:121–126.
38 Frick IM, Bjorck L, Herwald H. The dual role of the
contact system in bacterial infectious disease. Thromb Haemost 2007;98:497–502.
39 Kaplan AP, Ghebrehiwet B. The plasma bradykininforming pathways and its interrelationships with complement.
Mol Immunol 2010;47:2161–2169.
40 Yarovaya GA, Blokhina TB, Neshkova EA. Contact system. New concepts on activation mechanisms and bioregulatory functions. Biochemistry (Mosc) 2002;67:13–24.
41 Rojkjaer R, Schmaier AH. Activation of the plasma kallikrein/ kinin system on endothelial cell membranes. Immunopharmacology 1999;43:109–114.
42 Adib-Conquy M, Cavaillon JM. Compensatory antiinflammatory response syndrome. Thromb Haemost 2009;101:
36–47.
43 Ward NS, Casserly B, Ayala A. The compensatory antiinflammatory
response syndrome (CARS) in critically ill patients. Clin Chest Med 2008;29:617–625, viii
44 Osuchowski MF, Welch K, Siddiqui J, et al. Circulating
cytokine/inhibitor profiles reshape the understanding of the IRS/CARS continuum in sepsis and predict mortality. J Immunol2006;177:1967–1974
compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg 2002;89:1450–1456.
46 Power C, Fanning N, Redmond HP. Cellular apoptosis and organ injury in sepsis: A review. Shock 2002;18:197–211
47 Ward PA. Sepsis, apoptosis and complement. Biochem Pharmacol 2008;76:1383–1388.
48 Delano MJ, Thayer T, Gabrilovich S, et al. Sepsis
induces early alterations in innate immunity that impact mortality to secondary infection. J Immunol 2011;186:195–202.
49 Alves-Filho JC, Spiller F, Cunha FQ. Neutrophil paralysis in sepsis. Shock 2010;34(Suppl 1):15–21.
50 Nakajima Y, Mikami O, Yoshioka M, et al. Involvement of apoptosis in the endotoxemic lesions of the liver and kidneys of piglets. J Vet Med Sci 2000;62:621–626
51 Rahal L, Garrido AG, Cruz RJ Jr, et al. Fluid replacement with hypertonic or isotonic solutions guided by mixed
venous oxygen saturation in experimental hypodynamic sepsis. J Trauma 2009;67:1205–1212.
52Crouser ED, Julian MW, Weinstein DM, et al. Endotoxin- induced ileal mucosal injury and nitric oxide dysregulation are temporally dissociated. Am J Respir Crit Care Med 2000;161:1705–1712.
53 Kenney EM, Rozanski EA, Rush JE, et al. Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003-2007). J Am Vet Med Assoc 2010;236:83- 87
54 Ripanti D, Dino G, Piovano G, et al: Application of the Sequential Organ
Failure Assessment Score to predict outcome in critically ill dogs: preliminary results, SAT Schweiz Arch Tierheilkunde 154:325, 2012.
55 Dellinger R, Levy M, Rhodes A. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive care … [Internet]. 2013;41(2):580–637.
56 Butler AL. Goal-Directed Therapy in Small Animal Critical Illness. Vet Clin North Am - Small Anim Pract [Internet]. Elsevier Inc; 2011;41(4):817–38.
57 Ford H, Systems H, Re- CW. The Ne w E n g l a nd Jour n a l o f Me d ic i ne EARLY GOAL-DIRECTED THERAPY IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK. 2001;345(19):1368–77.
58. Aldrich J, Haskins S. Monitoring the critically ill patient. In: Bonagura J, Kirk R,editors. Current veterinary therapy. Philadelphia: WB Saunders; 1995. p. 98–105.
59 Hayashi Y, Maruyama K, Takaki O, et al. Optimal placement of CVP catheter in paediatric cardiac patients. Can J Anaesth 1995;46(6):479–82.
60 Chow R, Kass P, Haskins S. Evaluation of peripheral and central venous pressure in awake dogs and cats. Am J Vet Res 2006;67(12):1987–91
61 Bulmer BJ. Cardiovascular Dysfunction in Sepsis and Critical Illness. Vet Clin North Am - Small Anim Pract [Internet]. Elsevier Inc; 2011;41(4):717–26.
62 Acierno M, Seaton D, Mitchell MA, et al. Agreement between directly measuredblood pressure and pressures obtained with three veterinary-specific oscillometric units in cats. J Am Vet Med Assoc 2010;237:402–6.
63Srisawat N, Hoste E, Kellum J. Modern classification of acute kidney injury.Blood Purif 2010;29(3):520–4.
64 Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure—definition, outcomemeasures, animal models, fluid therapy and information technology needs:the Second International Consensus Conference of the Acute Dialysis QualityInitiative (ADQI) Group. Crit Care 2004;8(2):R204–12.
65 Stevenson CK, Kidney BA, Duke T, et al. Serial blood lactate concentrations in systemically ill dogs. Vet Clin Pathol 2007;36(3):234–9.
66 Hackett TB: Physical examination and daily assessment of the critically ill patient. In Silverstein- Hopper editors. Small Animal Critical Care St Louis (MO): Saunders Elsevier; 2009; 32-36.
67 Prittie J. Optimal endpoints of resuscitation and early goal-directed therapy. J Vet Emerg Crit Care 2006;16(4):329–39.
68 Pope J, Jones AE, Gaieski DF, et al. Multicenter study of central venous oxygen saturation (ScvO2) as a predictor of mortality in patients with sepsis. Ann Emerg Med 2010;55(1):40– 6.
69 Lima A, van Bommel J, Jansen TC, et al. Low tissue oxygen saturation at the end of early goal-directed therapy is associated with worse outcome in critically ill patients. Crit Care 2009;13(S5):S13.
70 Englehart M, Schreiber M. Measurement of acid-base resuscitation endpoints: lactate, base deficit, bicarbonate or what? Curr Opin Crit Care 2006;12(6):259–574.
71 Hume D, Drobatz K, Hess R. Outcome of dogs with diabetic ketoacidosis: 127 dogs (1993– 2003). J Vet Intern Med 2006;20(3):547–55
72 Hagman R, Reezigt BJ, Bergstrom Ledin H, et al. Blood lactate levels in 31 female dogs with pyometra. Acta Vet Scand 2009;51:2–12.7 dogs (1993–2003). J Vet Intern Med 2006;20(3):547–55.
73 Dow S, Curtis C, Jones R, et al. JAVM.: Bacterial culture of blood from critically ill dogs and cats: 100 cases (1985-1987). 195:113-117, 1989
74 Ratzinger F, Eichbichler K, Schuardt M, Tsirkinidou I, Mitteregger D, Haslacher H, et al. Sepsis in standard care : patients ’ characteristics , effectiveness of antimicrobial therapy and patient outcome — a cohort study. Infection [Internet]. Springer Berlin Heidelberg; 2015;345–52.
75 Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, et al: Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care 2004;19:152–157
77Tang BM, Eslick GD, Craig JC, et al: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: Systematic review and metaanalysis. Lancet Infect Dis 2007; 7:210–217
78Puskarich MA, Trzeciak S, Shapiro NI, et al: Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol, Crit Care Med 39(9):2066, 2011
79 Butler AL. Goal-Directed Therapy in Small Animal Critical Illness. Vet Clin North Am - Small Anim Pract [Internet]. Elsevier Inc; 2011;41(4):817–38.
80.Hayes G, Benedicenti L, Mathews K. Retrospective cohort study on the incidence of acute kidney injury and death following hydroxyethyl starch (HES 10% 250/0.5/5:1) administration in dogs (2007-2010).J Vet Emerg Crit Care. 2016 Jan-Feb;26(1):35-40
81Trow AV, Rozanski EA, Delaforcade AM, Chan DL. Evaluation of use of human albumin in critically ill dogs: 73 cases (2003-2006)J Am Vet Med Assoc. 2008 Aug 15;233(4):607- 12.
82 Mazzaferro E, Powell LL. Fluid therapy for the emergent small animal patient: Crystalloids, colloids, and albumin products. Vet Clin North Am - Small Anim Pract [Internet]. Elsevier Inc; 2013;43(4):721–34.
83 Minneci PC, Deans KJ, Banks SM, Costello R, Csako G, Eichacker PQ, et al. Differing effects of epinephrine , norepinephrine , and vasopressin on survival in a canine model of septic shock. 2004;20892:2545–54.
84 Shapiro D, Loiacono L. Mean arterial pressure: therapeutic goals and pharmacologi csupport. Crit Care Clin 2010;26(2):285–93.
85 Long K, Kirby R. An update on cardiovascular adrenergic receptor physiologyand potential pharmacological applications in veterinary critical care. J VetEmerg Crit Care 2008;18(1):2– 25.
86 Scroggin R, Quandt J. The use of vasopressin for treating vasodilatory shock and cardiopulmonary arrest. J Vet Emerg Crit Care 2009;19(2):145–57.
87 Silverstein D. Vasopressin. In: Silverstein D, Hopper K, editors. Small animal critical care medicine. St Louis (MO): Saunders Elsevier; 2009. p. 759–62.
88 Schenarts P, Sagraves SG, Bard MR, et al. Low-dose dopamine: a physiologically based review. Curr Surg 2006;63(3):219–25.
89 Wohl J, Clark T. Pressor therapy in critically ill patients. J Vet Emerg Crit Care 2000;10(1):21–34.
90 Moran J, Chapman M, O’Fathartaigh M, et al. Hypocortisolemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 1994;20(7):489–95.
91 Beishuizen A, Thijs L. Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab 2001;15(4):513–31
92 Soni A, Pepper GM, Wyrwinski PM, et al. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels.Am J Med 1995;98(3):266–71.
93 Burkitt JM, Haskins SC, Nelson RW, et al. Relative adrenal insufficiency in dogs with sepsis. J Vet Intern Med 2007;21(2):226–31.
94 Martin LG. Critical Illness – Related C o r t i c o s t e ro i d I n s u ff i c i e n c y i n Small Animals. Vet Clin NA Small Anim Pract [Internet]. Elsevier Ltd; 2011;41(4):767–82.
95 Bentley A, Otto C, Shofer F. Comparison of dogs with septic peritonitis: 1988–1993 versus 1999–2003. J Vet Emerg Crit Care 2007;17(4):391–8.
96 The NICE-SUGAR Study Investigators: Intensive versus conventional glucose control in critically ill9; patients. N Engl J Med 2003 60:1283–1297
97 Corstjens AM, Horst ICC Van Der, Zijlstra JG, Groeneveld ABJ, Zijlstra F, Tulleken JE, et al. Hyperglycaemia in critically ill patients : marker or mediator of mortality ? 2006;5:5–9.
98 Chan DL. Nutritional requirements of the critically ill patient. Clin Tech Small Anim Pract. 2004;19(1):1–5.
99 Corstjens AM, Horst ICC Van Der, Zijlstra JG, Groeneveld ABJ, Zijlstra F, Tulleken JE, et al. Hyperglycaemia in critically ill patients : marker or mediator of mortality ? 2006;5:5–9.
100 Silverstein DC, Ryan MJ. SIRS, MODS and sepsis: treatment options; in Proceedings 13th EVECCS congresse Prague, June 2014
101 Keir I, Kellum J a. Acute kidney injury in severe sepsis: Pathophysiology, diagnosis, and treatment recommendations. J Vet Emerg Crit Care (San Antonio) [Internet]. 2015;25(2):200–9.
102 Alan G Ralph, Benjamin M Brainard: Hypercoaugulable states. In Silverstein, Hopper Small Animal Critical Care St. Louis, MO: Saunders Elsevier; 2014
103 Wiese AJ, Muir WW III, Wittum TE. Characteristics of pain and response to analgesic treatment in dogs and cats examined at a veterinary teaching hospital emergency service. J Am Vet Med Assoc 2005;226(12):2004–9
104 Chapman CR, Tuckett RP, Song CW. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. The Journal of Pain 2008;9(2):122–45
105
106 Mazzaferro EM: Oxygen therapy. In In Silverstein, Hopper Small Animal Critical Care St. Louis, MO: Saunders Elsevier; 2014
107 DeClue AE, Sharp CR, Harmon M. Plasma inflammatory mediator concentrations at ICU admission in dogs with naturally developing sepsis. J Vet InternMed 2012; 26(3):624–630.
108 Kocaturk M, Martinez S, Eralp O, et al. Prognostic value of serum
acute-phase proteins in dogswith parvoviral enteritis. J Small Anim Pract 2010; 51(9):478– 483.
109 deLaforcadeAM, Rozanski EA, Freeman LM, et al. Serial evaluation of protein C and antithrombin in dogswith sepsis. J Vet Intern Med 2008; 22(1):26–30.
110 Kenney EM, Rozanski EA, Rush JE, et al. Association between out- come and organ system dysfunction in dogs with sepsis: 114 cases (2003–2007). J Am VetMed Assoc 2010; 236(1):83–87.
111 Hayes G, Mathews K, Doig G, Kruth S, Boston S, Nykamp S, et al. The Acute Patient Physiologic and Laboratory Evaluation (APPLE) Score: A Severity of Illness Str atification System for Hospitalized Dogs. 2010;1034–47.
112 Giunti M, Troia R, Bergamini PF, Dondi F. Prospective evaluation of the acute patient physiologic and laboratory evaluation score and an extended clinicopathological profile in dogs with systemic inflammatory response syndrome. J Vet Emerg Crit Care (San Antonio) [Internet]. 2014;00(0):1–8.
113 Hayes G, Mathews K, Kruth S, Doig G, Dewey C. I l l n e s s S e v e r i t y S c o r e s in Vete r i n a r y M e d i c i n e : W h a t C a n W e Le a r n ? 2010;457–66.
114 King LG, Stevens MT, Ostro EN. A model for prediction of survival in critically ill dogs. J Vet Emerg Crit Care 1994;4:85–99.
115 King LG, Wohl JS, Manning AM, Hackner SG, Raffe MR, Maislin G. Evaluation of the survival prediction index as a model of risk stratification for clinical research in dogs admitted to intensive care units at four locations. 2000;20878.
116 Sch??ttler J, Neumann S. Interleukin-6 as a prognostic marker in dogs in an intensive care unit. Vet Clin Pathol. 2015;2:223–8.
117 Rau S, Kohn B, Richter C, Fenske N, Küchenhoff H, Hartmann K, et al. Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet Clin Pathol. 2007;36(3):253–60.
118 Conti-Patara A, de Araújo Caldeira J, de Mattos-Junior E, de Carvalho H da S, Reinoldes A, Pedron BG, et al. Changes in tissue perfusion parameters in dogs with severe sepsis/septic shock in response to goal-directed hemodynamic optimization at admission to ICU and the relation to outcome. J Vet Emerg Crit Care. 2012;22(4):409–18.
119 Hamacher L, D??rfelt R, M??ller M, Wess G. Serum Cardiac Troponin I Concentrations in Dogs with Systemic Inflammatory Response Syndrome. J Vet Intern Med. 2015;29(1):164– 70.
120 Gebhardt C, Hirschberger J, Rau S, Arndt G, Krainer K, Schweigert FJ, et al. Use of C- reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis. J Vet Emerg Crit Care [Internet]. 2009;19(5):450–8.
121 Torrente C, Manzanilla EG, Bosch L, Fresno L. Plasma iron , C-reactive protein , albumin , and plasma fibrinogen concentrations in dogs with systemic inflammatory response syndrome. 2015;25(5):611–9.
122 Holowaychuk MK, Hansen BD, DeFrancesco TC, Marks SL. Ionized hypocalcemia in critically ill dogs. J Vet Intern Med. 2009;23(3):509–13.
123 Holowaychuk MK. Hypocalcemia of Critical Illness in Dogs and Cats. Vet Clin North Am - Small Anim Pract [Internet]. Elsevier Inc; 2013;43(6):1299–317.
124 Luschini MA, Fletcher DJ, Schoeffler GL. Incidence of ionized hypocalcemia in septic dogs and its association with morbidity and mortality: 58 cases (2006-2007). J Vet Emerg Crit Care. 2010;20(4):406–12.
125 Liu HH, Zhang MW, Guo JB, Li J, Su L. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria. Irish J Med Sci (1971 -) [Internet]. 2016.
126 Sugita H, Kinoshita Y, Baba H. The duration of SIRS before organ failure is a significant prognostic factor of sepsis. Int J Emerg Med [Internet]. 2012;5(1):44
127 Kilpatrick S, Dreistadt M, Frowde P, Powell R, Milne E, Smith S, et al. Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis. PLoS One [Internet]. 2016;11(1):e0146560
128 Pashmakova MB, Bishop MA, Steiner JM, Suchodolski JS, Barr JW. Evaluation of serum thyroid hormones in dogs with systemic inflammatory response syndrome or sepsis. J Vet Emerg Crit Care. 2014;24(3):264–71.
129 Ateca LB, Drobatz KJ, King LG. Organ dysfunction and mortality risk factors in severe canine bite wound trauma. 2014;24(6):705–14.
130 Brattig NW, Schwohl A, Rickert R, Büttner DW. The filarial parasite Onchocerca volvulus generates the lipid mediator prostaglandin E(2). Microbes Infect [Internet]. 2006 Mar [cited 2016 Jul 2];8(3):873–9.
131 Funk C. Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology. Science. 2001. 291:1871-1875.
132 Mrljak V, Ku??er N, Kule?? J, Tvarijonaviciute A, Brklja??i?? M, Crnogaj M, et al. Serum concentrations of eicosanoids and lipids in dogs naturally infected with Babesia canis. Vet Parasitol. 2014;201(1-2):24–30.
133 Köster LS, Steiner JM, Suchodolski JS, Schoeman JP. Serum canine pancreatic-specific lipase concentrations in dogs with naturally occurring Babesia rossi infection. J S Afr Vet Assoc [Internet]. 2015;86(1):4–7.
134 Osterbur K, Whitehead Z, Sharp CR, DeClue a. E. Plasma nitrate/nitrite concentrations in dogs with naturally developing sepsis and non-infectious forms of the systemic inflammatory response syndrome. Vet Rec. 2011;169(21):554–554
135 Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, et al. Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)*. Crit Care Med [Internet]. 2004;32(1).
136 Irkebøen KAK, Trand ØAS. The role of nitric oxide in sepsis – an overview. 1999;275– 88.
137 Mastrorilli C, Dondi F, Agnoli C, Turba ME, Vezzali E, Gentilini F. Clinicopathologic features and outcome predictors of Leptospira interrogans Australis serogroup infection in dogs: a retrospective study of 20 cases (2001-2004). J Vet Intern Med [Internet]. 2007;21(1):3–10.
138 Declue AE, Delgado C, Chang CH el al. Clinical and immunologic assessment of sepsis and the systemic infiammatory response syndrome in cat. J AM Vet Med Assoc 2011; 238:890-897
139 Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence [Internet]. 2014;5(1):4–11.
140 Bentley AM, Otto CM, Shofer FS. Comparison of dogs with septic peritonitis: 1988–1993 versus 1999–2003. J Vet Emerg Crit
Care 2007;17:391–398
141 Goyette RE, Key NS, Ely EW. Hematologic Changes in Sepsis and Their Therapeutic Implications. 2004;1(212):645–59.
142 Langenfeld, Livingstong DH, Machiedo GW. Red cell deformability is an early indicator of infection. Sugery 1991; 110:398-403; discussion 403-404.
144 Baskurt OK, Gelmont D, Meiselman HJ. Red blood cell deformabilità in sepsis. Am J Respir Crit Care
Med. 1998;157:421-427.
145 von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care
Med. 1999;27:2630-2639.
146 Lynch AM, Respess M, Boll AE, Bozych M, Mcmichael M, Fletcher DJ, et al. Hospital-acquired Anemia in Critically Ill Dogs and Cats: A Multi-Institutional Study. J Vet Intern Med. 2016;30(1):141–6.